Our Experience

PV Focus is a newly created company owned and managed by Thierry Hamard. With a Pharmacist background, Thierry has over 10 years of auditing experience across a spectrum of processes related to Clinical Research throughout the world. For the last 5 years, he has focused on Pharmacovigilance processes where he has experienced first-hand Pharmacovigilance Inspections performed by different Regulatory Authorities (FDA, MHRA).

>> More about Academic Background
>> More about Experience in Pharmacovigilance Auditing and Regulatory Inspections
>> More about Other Experience


Academic Background:

  • Pharmacy Doctorate, University of Angers, France
  • Post-graduate Diploma in Quality Management, University of Angers, France

Experience in Pharmacovigilance Auditing and Regulatory Inspections:

Thierry has more than 5 years of Global Pharmacovigilance Auditing experience and is now a member of the BARQA Good Pharmacovigilance Practice Committee.

Highlights include major corporate audits and MHRA and FDA Pharmacovigilance Inspections, widely recognized as leading Regulatory Authorities in this field. The following table details the most significant projects:

Period Project Role of T. Hamard Countries Covered
2006 Audit of Pharmacovigilance Operations at the Spanish subsidiary of Bayer HealthCare Led the preparation, conduct, and reporting of the audit. This audit was performed wit the assistance of 2 Bayer HealthCare auditors. Spain
2006

Review of Clinical Safety and Pharmacovigilance Processes at the UK affiliate of Kyowa Hakko, including aspects related to EU/RoW coordinating role

Led the preparation, conduct, and reporting of the audit. UK
2006 Review of Clinical Safety and Pharmacovigilance Processes within Grünenthal Corporate Headquarters and two selected affiliates Led the preparation, conduct, and reporting of the audit. This audit was performed together with an auditor from Grünenthal Corporate Quality Assurance. Germany and other European countries
2006

Audit of Clinical Safety Service Provider for Biopartners

Led the preparation, conduct, and reporting of the audit. Germany
2006 Review of the Medical Information Processes at provider contracted by Bayer Consumer Care Division Led the preparation, conduct, and reporting of the audit. UK
2006

Review of EU Drug Safety Processes at the European Drug Safety Unit at GPC Biotech

Led the preparation, conduct, and reporting of the audit. Germany
2006 Audit of Clinical Safety Service Provider for BioVex Led the preparation, conduct, and reporting of the audit. UK
2005

Mock Inspection of
Global Drug Safety (GDS), Bayer HealthCare AG

Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team Germany
2005 Audit of Pharmacovigilance Operations at the French subsidiary of Bayer HealthCare AG Led the preparation, conduct, and reporting of the audit. France
2005 Follow-up of EMEA Pharmacovigilance Inspection at the UK Drug Safety Unit of Schering-Plough Consulting on the actions to complete in order to promote success of future inspections UK
2005 Review of the Medical Information Processes at the Call Center contracted by Bayer Consumer Care Division Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team UK
2004 Audit of Global Pharmacovigilance Unit of Altana Pharma Led the preparation, conduct, and reporting of the audit. T. Hamard was the sole member of the audit team. The audit covered the activities of the Global Pharmacovigilance Unit of Altana Pharma, which also assumed the responsibility of Local Drug Safety Unit for Germany Germany
2004 Audit of Pharmacovigilance processes at the OTC Products Division of Bayer Led the preparation, conduct, reporting and follow-up of the audit Germany, Spain and USA
2004 Audit of Pharmacovigilance processes at the Biological Products Division of Bayer Led the preparation, conduct, reporting and follow-up of the audit USA
2004 Audit of Pharmacovigilance processes at a partner company Led the preparation, conduct, reporting and follow-up of the audit UK
2003 Preparation, conduct & follow-up of local Pharmacovigilance Inspection Led the preparation, attended the conduct and contributed to the follow-up for a MHRA Pharmacovigilance Inspection UK
2002-2003 System audit of Global Pharmacovigilance Processes for Bayer Led the preparation, conduct, reporting and follow-up of the audit UK, USA, Germany, Italy, Spain, Mexico, Japan and China
2002 Follow-up of local Pharmacovigilance Inspection Contributed to the identification of corrective actions Portugal
2001 Preparation for local Pharmacovigilance Inspection Supervised the preparation, conduct and reporting of a pre-inspection audit by a corporate auditor USA
2001 Preparation for local Pharmacovigilance Inspection Led the preparation and supervised the conduct and reporting of a pre-inspection audit by a contract auditor France
2001 Preparation & follow-up of FDA Inspection at the corporate Pharmacovigilance department Led the preparation, conduct and reporting of a pre-inspection audit Germany
2000 Follow-up of local Pharmacovigilance Inspection Involvement for corrective actions after inspection The Netherlands

Other Experience

10 years of auditing experience

  • Pharmacovigilance and System Auditing:
    Head, Global System Audit Management in Bayer for 4 years. Responsibilities included establishing this newly created function, leading global audit teams in the evaluation of product development processes, the identification of areas for improvement and the definition of corrective actions.

  • Clinical Quality Assurance and Investigator Site Auditing:
    This included leading the design and global implementation of the procedures and tools to support all site audit activities, including a compliance data analysis and reporting tool to evaluate process performance. Leading the planning, conduct and reporting of study related audit activities for multiple clinical development projects. Managing the ISO 9000 certification process.

  • Global experience:
    Held positions of increasing importance in France, Switzerland, the United Kingdom, the USA and Germany. Led audits for sites and systems throughout the world.